Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Apr 6;20:1691–1701. doi: 10.1016/j.csbj.2022.04.004

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 The Authors. Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

PMC Copyright notice

Fig. 3 — Comparisons of immune signatures and immunotherapy response among the stemness subtypes of LUAD. Comparisons of the expression levels of human leukocyte antigen (HLA) genes (A) and predicted response rates to immune checkpoint inhibitors (ICIs) (B) among the stemness subtypes of LUAD. C. Comparisons of the response rates to ICIs in five cancer cohorts treated with ICIs. The one-way ANOVA test P-values are shown in (A). NSCLC: non-small-cell lung cancer; ccRCC: clear cell renal cell carcinoma; BLCA: bladder carcinoma. * P < 0.05, ** P < 0.01, *** P < 0.001, ^ns not significant.